Targeting immunosuppressive cytokines like transforming growth factor beta (TGF-β), often elevated in PCa, represents another approach to improve T-cell infiltration and enhance TCE efficacy, particularly in resistant lesions [90]. Here, TGFB1 is linked to posterior cortical atrophy.